Diasorin SpA (WBO:DIAS) Change In Inventory: €0 Mil (TTM As of Dec. 2025)


WBO:DIAS Diasorin SpA WBO:DIAS
74 GF Score
Price €69.94
GF Value €90.02
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Diasorin SpA Change In Inventory?

Diasorin SpA WBO:DIAS +5.17% 74 Change In Inventory is €0 Mil as of Dec. 2025. GuruFocus rates WBO:DIAS with a GF Score™ of 74/100 and a GF Value™ of €90.02 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Diasorin SpA's change in inventory for the quarter that ended in Dec. 2025 was €0 Mil. It means Diasorin SpA's inventory stayed the same from Sep. 2025 to Dec. 2025 .

Diasorin SpA's change in inventory for the fiscal year that ended in Dec. 2025 was €34 Mil. It means Diasorin SpA's inventory declined by €34 Mil from Dec. 2024 to Dec. 2025 .

Diasorin SpA's Total Inventories for the quarter that ended in Dec. 2025 was €335 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Diasorin SpA's Days Inventory for the quarter that ended in Dec. 2025 was 140.60.

Inventory Turnover measures how fast the company turns over its inventory within a year. Diasorin SpA's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.65.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Diasorin SpA's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.57.


Diasorin SpA  (WBO:DIAS) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Diasorin SpA's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=167.302/108.582*365 / 4
=140.60

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Diasorin SpA's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Diasorin SpA's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diasorin SpA Change In Inventory Related Terms


Diasorin SpA Change In Inventory Historical Data

* Premium members only.

The historical data trend for Diasorin SpA's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA Change In Inventory Chart

Diasorin SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.91 -26.23 -4.77 -16.98 34.06

Diasorin SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WBO:DIAS
74GF Score
Diasorin SpA WBO:DIAS
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diasorin SpA Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €0 Mil mean?
Diasorin SpA (WBO:DIAS) has a Change In Inventory of €0 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Diasorin SpA and its competitors.
Is Diasorin SpA's Change In Inventory too high?
Diasorin SpA's current Change In Inventory is €0 Mil. Overall, Diasorin SpA has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diasorin SpA's Change In Inventory compare to TMO and DHR?
Diasorin SpA's Change In Inventory of €0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Diagnostics & Research company?
A good Change In Inventory depends on the Medical Diagnostics & Research industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Diasorin SpA and its competitors. Diasorin SpA's current Change In Inventory is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diasorin SpA stock overvalued right now?
Based on GuruFocus' analysis, Diasorin SpA (WBO:DIAS) is currently considered Modestly Undervalued. The stock's GF Value™ is €90.02, compared to a current price of €69.94 — trading 22.3% below its estimated fair value. The current Change In Inventory is €0 Mil. Diasorin SpA's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Diasorin SpA (WBO:DIAS), the current Change In Inventory is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diasorin SpA (WBO:DIAS) Overvalued in 2026?

Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued. The current stock price of €69.94 is trading 22.3% below its estimated GF Value™ of €90.02. GuruFocus considers Diasorin SpA to be Modestly Undervalued.

Key valuation signals for WBO:DIAS:

  • Change In Inventory: €0 Mil
  • GF Value™: €90.02 vs. price of €69.94 (22.3% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the WBO:DIAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Diasorin SpA Business Description

Address Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
74GF Score

Get the complete analysis for WBO:DIAS

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.94
Price
€90.02
GF Value